#ProcessaPharmaceuticals to Conduct Next Generation #Chemotherapy-#Capecitabine Phase 2 Trial Based on FDA Guidance and Project #Optimus #Oncology Initiative $PCSA 1stoncology.com/blog/processa-…

#Redx Presents Preclinical Efficacy Data for #RXC007 Showing Significant Results in #CancerAssociatedFibrosis Models $REDX 1stoncology.com/blog/redx-pres…

#Regeneron Announces #InvestorConference Presentations $REGN 1stoncology.com/blog/regeneron…

#TaihoPharmaceutical Enters into a Clinical Trial Agreement with #ArcusBiosciences and #GileadSciences 1stoncology.com/blog/taiho-pha…

#Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) $RARE 1stoncology.com/blog/ultrageny…

#OncoSec Announces Closing of $1.33 Million Registered #DirectOffering Priced #AtTheMarket Under Nasdaq Rules $ONCS 1stoncology.com/blog/oncosec-a…

#CTIBioPharma World-Wide Sales for #VONJO was 24.1m USD in Q1 2023 (Up 14%) 1stoncology.com/blog/10-q-quar…

#PhioPharmaceuticals Presents Preclinical Study Showing #INTASYL™ Treatment of #NKCells More than Doubles Ability to Kill #TumorCells $PHIO 1stoncology.com/blog/phio-phar…

#HitGen Announces Drug Discovery Research Agreement with #ARaseTherapeutics 1stoncology.com/blog/hitgen-an…

#Navrogen Announces Publication of #NAV001 #AntibodyDrugConjugate Development and Efficacy in #HumoralImmunosuppressedCancers 1stoncology.com/blog/navrogen-…

#OncoResponse Awarded $13 Million in Funding from #CPRIT and Raises $14 Million in Added Funds from Investors to Advance #Cancer #Immunotherapy 1stoncology.com/blog/oncorespo…

#ImaginAb Advances Two #SolidTumor #RadiopharmaceuticalTherapy (#RPT) Candidates Towards Clinical Development 1stoncology.com/blog/imaginab-…

#MyeloidTherapeutics Announces $73 Million Financing to Advance #mRNAbasedImmunotherapy Pipeline 1stoncology.com/blog/myeloid-t…

#Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead #Therapeutic #Oncology Candidate, #FID007 at #ASCO23 $FLGT 1stoncology.com/blog/fulgent-a…

#PoseidaTherapeutics Presents Encouraging Preclinical Data Across its Gene Therapy Programs at the #ASGCT23 1stoncology.com/blog/poseida-t…

#BridGeneBiosciences to Present at #HippoPathwayTargetedDrug Development Summit 1stoncology.com/blog/bridgene-…

#LadRx Announces Reverse Stock Split Effective as of May 17, 2023 $LADX 1stoncology.com/blog/ladrx-ann…

#Oncomatryx acquires #TubePharmaceuticals to consolidate its pioneering pipeline of #ADCs targeting the #Tumor microenvironment 1stoncology.com/blog/oncomatry…

#AdicetBio Presents Positive #Preclinical Data on #ADI270 at the #ASGCT23 $ACET 1stoncology.com/blog/adicet-bi…

#FDA clears #Imugene #IND to commence #OnCARlytics first-in-class clinical study $IMU 1stoncology.com/blog/fda-clear…